Choreo, LLC Genmab A/S Transaction History
Choreo, LLC
- $7.23 Billion
- Q2 2025
A detailed history of Choreo, LLC transactions in Genmab A/S stock. As of the latest transaction made, Choreo, LLC holds 25,794 shares of GMAB stock, worth $748,799. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,794
Previous 26,040
0.94%
Holding current value
$748,799
Previous $509,000
4.52%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding GMAB
# of Institutions
255Shares Held
65.2MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$310 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$230 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$147 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$104 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$100 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $19.1B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...